Literature DB >> 8721783

Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.

A Sainsbury1, I Cusin, P Doyle, F Rohner-Jeanrenaud, B Jeanrenaud.   

Abstract

The aim of this work was to determine the possible inter-relationship between neuropeptide Y (NPY, a hypothalamic stimulator of feeding) and adipose tissue expression of the ob protein (a novel potent inhibitor of feeding). Such a relationship could be of importance in the maintenance of normal body weight. To this end, normal rats were intracerebroventricularly (i.c.v.) infused for 6 days with NPY. NPY infusion resulted in hyperphagia and a marked increase in adipose tissue ob mRNA levels. The effect of NPY on ob expression persisted when hyperphagia was prevented by pair-feeding, and was reversed following cessation of NPY infusion. Basal and glucose-stimulated insulinaemia were increased by i.c.v. NPY infusion compared to control values, regardless of whether animals were ad libitum-fed or pair-fed. Cessation of NPY infusion was accompanied by normalisation of insulinaemia. These changes in insulinaemia produced by i.c.v. NPY infusion paralleled the observed changes in ob expression. When normal rats were made hyperinsulinaemic-euglycaemic for 24 h, such hyperinsulinaemia also resulted in increased ob mRNA levels in white adipose tissue. This suggested that NPY-induced hyperinsulinaemia could be responsible for the upregulation of ob mRNA levels of NPY-infused rats. It is concluded that central (i.c.v.) NPY infusion increases adipose tissue ob expression, a functional relationship that is linked, at least in part, via NPY-induced hyperinsulinaemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721783     DOI: 10.1007/BF00418353

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

Authors:  R Vettor; N Zarjevski; I Cusin; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

2.  The ob gene and insulin. A relationship leading to clues to the understanding of obesity.

Authors:  I Cusin; A Sainsbury; P Doyle; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetes       Date:  1995-12       Impact factor: 9.461

3.  Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.

Authors:  M Maffei; J Halaas; E Ravussin; R E Pratley; G H Lee; Y Zhang; H Fei; S Kim; R Lallone; S Ranganathan
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

Review 4.  Neuropeptide Y and energy balance: one way ahead for the treatment of obesity?

Authors:  S Dryden; H Frankish; Q Wang; G Williams
Journal:  Eur J Clin Invest       Date:  1994-05       Impact factor: 4.686

5.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

6.  The role of neuropeptide Y in the antiobesity action of the obese gene product.

Authors:  T W Stephens; M Basinski; P K Bristow; J M Bue-Valleskey; S G Burgett; L Craft; J Hale; J Hoffmann; H M Hsiung; A Kriauciunas
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

7.  Transient increase in obese gene expression after food intake or insulin administration.

Authors:  R Saladin; P De Vos; M Guerre-Millo; A Leturque; J Girard; B Staels; J Auwerx
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

8.  Effects of the obese gene product on body weight regulation in ob/ob mice.

Authors:  M A Pelleymounter; M J Cullen; M B Baker; R Hecht; D Winters; T Boone; F Collins
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

10.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.

Authors:  L A Campfield; F J Smith; Y Guisez; R Devos; P Burn
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

  10 in total
  6 in total

Review 1.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  Effects of butorphanol on feeding and neuropeptide Y in the rat.

Authors:  A Mitra; C M Kotz; E M Kim; M K Grace; M A Kuskowski; C J Billington; A S Levine
Journal:  Pharmacol Biochem Behav       Date:  2011-09-07       Impact factor: 3.533

4.  Hypothalamic Y2 receptors regulate bone formation.

Authors:  Paul A Baldock; Amanda Sainsbury; Michelle Couzens; Ronaldo F Enriquez; Gethin P Thomas; Edith M Gardiner; Herbert Herzog
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

5.  Estrogen-related receptor β deficiency alters body composition and response to restraint stress.

Authors:  Mardi S Byerly; Roy D Swanson; G William Wong; Seth Blackshaw
Journal:  BMC Physiol       Date:  2013-09-22

6.  Dissecting Long-Term Glucose Metabolism Identifies New Susceptibility Period for Metabolic Dysfunction in Aged Mice.

Authors:  Anuradha Chauhan; Heike Weiss; Franziska Koch; Saleh M Ibrahim; Julio Vera; Olaf Wolkenhauer; Markus Tiedge
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.